EXICURE, INC. Other Non-Current Liabilities
EXICURE, INC. (XCUR) had Other Non-Current Liabilities of $0 as of 2022-12-31, per its 10-K filed 2023-03-27.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2023-03-27
- 2022-12-31: Other Liabilities, Noncurrent $0.00.
- 2022-09-30: Other Liabilities, Noncurrent $0.00.
- 2022-06-30: Other Liabilities, Noncurrent $0.00.
- 2022-03-31: Other Liabilities, Noncurrent $0.00.
| Period end | Other Liabilities, Noncurrent | Other Liabilities, Noncurrent as first filed |
|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-27 | |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $656.00K 10-K · filed 2023-03-27 | |
| 2021-09-30 | $656.00K 10-Q · filed 2021-11-19 | |
| 2021-06-30 | $656.00K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $656.00K 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $656.00K 10-K · filed 2022-03-25 | |
| 2020-09-30 | $656.00K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $0.00 10-K · filed 2021-03-11 | $59.00K 10-K · filed 2020-03-10 |
| 2019-09-30 | $144.00K 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $226.00K 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $380.00K 10-Q · filed 2019-05-08 | |
| 2019-01-01 | $381.00K 10-K · filed 2020-03-10 | |
| 2018-12-31 | $39.00K 10-K · filed 2020-03-10 | |
| 2018-09-30 | $42.00K 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $275.00K 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $277.00K 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $278.00K 10-K/A · filed 2019-09-23 | |
| 2017-09-30 | $279.00K 10-Q · filed 2017-11-14 | |
| 2016-12-31 | $281.00K 10-K · filed 2018-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |